We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pars Plana Surgical Capsulotomy for Posterior Capsular Opacification (Capsulotomy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00964613
Recruitment Status : Completed
First Posted : August 25, 2009
Last Update Posted : August 7, 2015
Sponsor:
Collaborator:
Pakistan Ministry of Health
Information provided by (Responsible Party):
Jamshed Ahmed, Dow University of Health Sciences

Brief Summary:
Cataract is a leading cause of Global blindness. After cataract surgery nearly half of the people become blind due to posterior capsular opacification. The only solution for this problem is LASER capsulotomy. Laser machine is not available in remote areas especially in underdeveloped countries. The solution of this problem is surgical capsulotomy which can be performed any where.

Condition or disease
Blindness

Detailed Description:
posterior capsular opacification is treated by YAG laser capsulotomy. this require sophisticated technology ans specific environment which is not possible in underdeveloped countries. we describe a method in which posterior capsular opacification could be managed by using only a 27 Gauge needle through pars plana. opacified posterior capsule is under tension that is why a small puncture results in a large central opening

Study Type : Observational
Actual Enrollment : 176 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pars Plana Surgical Capsulotomy for Posterior Capsular Opacification
Study Start Date : January 2008
Primary Completion Date : January 2009
Study Completion Date : January 2009




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year to 95 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients having posterior capsular opacification
Criteria

Inclusion Criteria:

  • Patients with Posterior capsular opacification
  • Both Sexes
  • All ages

Exclusion Criteria:

  • Retinal disease
  • Uncontrolled Glaucoma
  • Corneal opacity

Responsible Party: Jamshed Ahmed, Assistant Professor, Dow University of Health Sciences
ClinicalTrials.gov Identifier: NCT00964613     History of Changes
Other Study ID Numbers: Surgical Capsulotomy
First Posted: August 25, 2009    Key Record Dates
Last Update Posted: August 7, 2015
Last Verified: August 2015

Keywords provided by Jamshed Ahmed, Dow University of Health Sciences:
Pars Plana
Surgical Capsulotomy
Posterior capsule opacification
visual outcome
Complications

Additional relevant MeSH terms:
Blindness
Capsule Opacification
Vision Disorders
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Eye Diseases
Signs and Symptoms
Cataract
Lens Diseases